Xiong Jie, Yang Lan, Deng Yu-Qing, Yan Si-Yu, Gu Jia-Min, Li Bing-Hui, Zi Hao, Ming Dao-Jing, Zeng Xian-Tao, Wang Yong-Bo
Center for Evidence-Based and Translational Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China.
Division of Medical Affairs, Zhongnan Hospital of Wuhan University, Wuhan, China.
Int J Cancer. 2022 Dec 15;151(12):2136-2143. doi: 10.1002/ijc.34228. Epub 2022 Aug 11.
Smoking and alcohol consumption are associated with bladder cancer risk in observational studies. We conducted a two-sample univariable and multivariable Mendelian randomization (MR) analysis to determine whether those associations are causal. We used 21, 126, 360, 39 single nucleotide polymorphisms (SNPs) as instrumental variables for number of cigarettes per day, lifetime smoking index, smoking initiation, and drinks per week, respectively. A total of 1115 cases with bladder cancer and 174 006 noncases from FinnGen consortium and 2883 cases with bladder cancer and 417 955 noncases from UK Biobank study were obtained. Genetic predisposition to cigarettes per day, lifetime smoking index and smoking initiation were positively associated with an increased risk of bladder cancer in both the FinnGen and UK Biobank consortium. The summary odds ratio (OR) of bladder cancer was 1.79 (95% confidence interval [CI], 1.31-2.45; P = .0002), 2.38 (95% CI, 1.45-3.88; P = .0005) and 1.91 (95% CI, 1.46-2.50; P = 1.59 × 10 ) for one SD increase in the number of cigarettes per day, lifetime smoking index and smoking initiation, respectively. The genetically instrumented number of drinks per week was not associated with bladder cancer (OR = 0.69; 95% CI, 0.44-1.10; P = .1237). Estimates were consistent in multivariable MR analyses by the adjustments of body mass index and education. Our study suggests a causal potential of the association of smoking but not alcohol consumption with bladder cancer according to current evidence.
在观察性研究中,吸烟和饮酒与膀胱癌风险相关。我们进行了一项两样本单变量和多变量孟德尔随机化(MR)分析,以确定这些关联是否具有因果关系。我们分别使用21、126、360、39个单核苷酸多态性(SNP)作为每日吸烟量、终生吸烟指数、开始吸烟和每周饮酒量的工具变量。从芬兰基因联盟获得了总共1115例膀胱癌病例和174006例非病例,以及从英国生物银行研究中获得了2883例膀胱癌病例和417955例非病例。在芬兰基因联盟和英国生物银行联盟中,每日吸烟量、终生吸烟指数和开始吸烟的遗传易感性均与膀胱癌风险增加呈正相关。每日吸烟量、终生吸烟指数和开始吸烟量每增加一个标准差,膀胱癌的汇总比值比(OR)分别为1.79(95%置信区间[CI],1.31 - 2.45;P = 0.0002)、2.38(95%CI,1.45 - 3.88;P = 0.0005)和1.91(95%CI,1.46 - 2.50;P = 1.59×10)。通过基因手段测量的每周饮酒量与膀胱癌无关(OR = 0.69;95%CI,0.44 - 1.10;P = 0.1237)。通过调整体重指数和教育程度进行的多变量MR分析中,估计结果一致。根据当前证据,我们的研究表明吸烟与膀胱癌之间存在因果关系的可能性,但饮酒与膀胱癌之间不存在因果关系。